The Role of Antipsychotics in the Management of Behavioural Symptoms in Children and Adolescents with Autism
- 1 January 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 69 (5), 535-548
- https://doi.org/10.2165/00003495-200969050-00003
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Ziprasidone in Adolescents with Autism: An Open-Label Pilot StudyJournal of Child and Adolescent Psychopharmacology, 2007
- Atypical Antipsychotics and Newer AntidepressantsEmergency Medicine Clinics of North America, 2007
- Naturalistic Impact of Second-Generation Antipsychotics on Weight GainAnnals of Pharmacotherapy, 2006
- Metabolic side effects of atypical antipsychotics in children: a literature reviewJournal of Psychopharmacology, 2005
- Ziprasidone: a novel psychotropic with unique propertiesExpert Review of Neurotherapeutics, 2004
- Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year StudiesAmerican Journal of Psychiatry, 2004
- Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptomsAmerican Journal of Psychiatry, 1984
- A Comparison of Haloperidol and Behavior Therapy and Their Interaction in Autistic ChildrenJournal of the American Academy of Child Psychiatry, 1978
- Long-Term Prognosis and the Response of Schizophrenic Children to Drug Therapy : A Controlled Study of TrifluoperazineAmerican Journal of Psychiatry, 1966
- Use of Chlorpromazine in Two Hundred Seventy-Eight Mentally Deficient PatientsArchives of Pediatrics & Adolescent Medicine, 1957